[ET Net News Agency, 7 August 2026] WUXI XDC (02268) rose 10.5% to HK$61.2.
It hits an intra-day high of HK$61.2, breaking above the 100-D SMA of HK$55.878, and an intra-day low of HK$55. The total shares traded was 6.19 million, with a value of HK$364.27m. The active buy/sell ratio is 75:25, with net buying turnover of HK$175.88m. UBS accounts for greatest net responsive buying turnover of HK$9.61m, with volume weighted average price of HK$58.77. J.P. MORGAN BRO (HK) accounts for greatest net responsive selling turnover of HK$43.38m, with volume weighted average price of HK$59.044. The stock has risen a combined 12.9% over the past 2 consecutive trading days.
Basic Information| Nominal | 61.200 | % Chg | +10.47% |
| High | 61.200 | Low | 55.000 |
| Shares Tr | 6.19m | Turnover | 364.27m |
| 10-D SMA | 54.240 | %H.V | 65.287 |
| 20-D SMA | 55.593 | VWAP | 58.892 |
| 50-D SMA | 53.992 | RSI14 | 61.693 |
Status: Breaking above the 100-D SMA, active buy/sell ratio is 75:25, with net buying turnover of HK$175.88m, rising a combined 12.9% over the past 2 consecutive trading days
Performance of stocks in the same sector or of relevance| Stock (Code) | Price (HK$) | Change (%) |
|---|
| WUXI XDC (02268) | 61.20 | +10.47 |
| GENSCRIPT BIO (01548) | 20.68 | +4.55 |
| INNOVENT BIO (01801) | 91.85 | +0.99 |
| WUXI BIO (02269) | 44.08 | +6.52 |
| WUXI APPTEC (02359) | 189.70 | +5.56 |
| TRANSTHERA-B (02617) | 12.20 | +5.81 |
| PHARMARON (03759) | 26.86 | +9.54 |
| BEONE MEDICINES (06160) | 203.80 | +2.16 |
| AKESO (09926) | 98.60 | +2.65 |
| REMEGEN (09995) | 83.55 | +5.09 |
(ed)